The Cooper Companies saw its stock plummet by 14.6% after revealing issues with U.S. channel inventory. An investigation now questions their transparency.

CooperCompanies hit $1.07bn in Q3 revenue but warned a US channel inventory reduction at CooperVision will weigh into the fourth quarter.

The latest CooperVision report reveals multifocal contact lenses ranked high among consumer anti-aging solutions, marking untapped opportunities for eye care professionals.

Needham lowered its price target for Cooper Companies (NASDAQ: COO) from $86 to $73. The firm cited reduced fiscal 2026 guidance and inventory de-stocking pressures within the CooperVision segment.

Patients accustomed to wearing hydrogel contact lenses reported better comfort and reduced dryness with silicone hydrogel lenses, according to data from CooperVision. “Although silicone hydrogel lenses now dominate new soft lens fits, approximately one-quarter of patients fit with daily disposable lenses globally are still wearing hydrogel materials,” study coauthor Jennifer Palombi, OD, FAAO, director of professional affairs, Americas, at CooperVision, told Healio. “Modern [silicone hydrogel] materials offer excellent oxygen transmission while also delivering comfort and

The Insomniac Hedge Fund Guy

CooperVision's Vision Centre opens in Southampton, marking a pivotal moment for eye care innovation with six groundbreaking products set to launch soon.

PHOENIX — The Myopia Collective added 22 new “change agents,” as well as its first group of 19 student change agents, to foster greater support for and awareness of childhood myopia treatment, according to a press release. The initiative, which was founded as a partnership between the American Optometric Association and CooperVision, has empowered designated change agents across the U.S. to lead advocacy efforts for childhood myopia. “It’s really giving that voice to the profession to say, ‘This is what we can do; this is how we’re able to drive this forward [and] make this a standard of care

Recent inventory reductions have led to a significant stock drop for The Cooper Companies. Discover the implications as investigations unfold over transparency issues.

Cooper Companies reported a Q3 fiscal 2026 earnings beat on an adjusted basis, but weak CooperVision sales and soft guidance overshadowed the results. The company also concluded a previously announced strategic review, signaling a focus on operational discipline rather than a major structural change, which appears to have disappointed investors expecting more.

An investigation has been initiated about Cooper Companies after its significant revenue guidance reduction and subsequent stock price drop, affecting many investors.

CooperCompanies (COO) reported fiscal third quarter 2026 revenue of $1.066 billion, up 1% year-over-year with 1% organic growth.GAAP diluted EPS rose to $2.24 from $0.49, primarily reflecting a $307.2 million discrete tax benefit from a favorable U.K. tax examination, while non-GAAP diluted EPS increased 4% to $1.15. Non-GAAP operating margin improved 30 basis points to 26% and free cash flow climbed 66% to $273.0 million. CooperVision revenue was flat at $717.0 million, with strength in toric and multifocal lenses offset by declines in sphere and Asia Pacific. CooperSurgical revenue grew 2% to $349.2 million, with fertility organic growth of 5%.The company repurchased $339.1 million of stock and expanded its authorization to $3 billion. Fiscal 2026 guidance calls for 2%–3% organic revenue growth and non-GAAP EPS of $4.51–$4.55, and management reaffirmed a long-term free cash flow objective exceeding $2.2 billion for 2026–2028.

$10 off plus free standard tracked delivery when you spend $99 or more on contact lenses. Shop now to save on all your favourite contact lens brands including Acuvue, Alcon and CooperVision as …